BRIBF
Price
$0.24
Change
+$0.01 (+4.35%)
Updated
Aug 1 closing price
Capitalization
180.48M
GNTA
Price
$3.72
Change
-$0.08 (-2.11%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
69.5M
Interact to see
Advertisement

BRIBF vs GNTA

Header iconBRIBF vs GNTA Comparison
Open Charts BRIBF vs GNTABanner chart's image
BRII BIOSCIENCE
Price$0.24
Change+$0.01 (+4.35%)
Volume$2.38K
Capitalization180.48M
Genenta Science SpA
Price$3.72
Change-$0.08 (-2.11%)
VolumeN/A
Capitalization69.5M
BRIBF vs GNTA Comparison Chart in %
Loading...
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRIBF vs. GNTA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIBF is a Hold and GNTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BRIBF: $0.24 vs. GNTA: $3.80)
Brand notoriety: BRIBF and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRIBF: 22% vs. GNTA: 4%
Market capitalization -- BRIBF: $180.48M vs. GNTA: $69.5M
BRIBF [@Biotechnology] is valued at $180.48M. GNTA’s [@Biotechnology] market capitalization is $69.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRIBF’s FA Score shows that 0 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • BRIBF’s FA Score: 0 green, 5 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRIBF and GNTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRIBF’s TA Score shows that 2 TA indicator(s) are bullish while GNTA’s TA Score has 6 bullish TA indicator(s).

  • BRIBF’s TA Score: 2 bullish, 4 bearish.
  • GNTA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GNTA is a better buy in the short-term than BRIBF.

Price Growth

BRIBF (@Biotechnology) experienced а -2.16% price change this week, while GNTA (@Biotechnology) price change was -1.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRIBF($180M) has a higher market cap than GNTA($69.5M). BRIBF YTD gains are higher at: 91.790 vs. GNTA (-12.644).
BRIBFGNTABRIBF / GNTA
Capitalization180M69.5M259%
EBITDAN/AN/A-
Gain YTD91.790-12.644-726%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BRIBFGNTA
RSI
ODDS (%)
Bullish Trend 2 days ago
25%
Bullish Trend 7 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
23%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKCOY13.05N/A
N/A
Park 24 Corp.
RPGRF153.63N/A
N/A
REA Group Ltd
SNVVF3.33N/A
N/A
Step Energy Svcs Ltd.
BRRE7.75N/A
N/A
Blue Ridge Real Estate Co.
FXLG38.00-1.00
-2.56%
F.S. Bancorp

BRIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRIBF has been loosely correlated with HLVX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRIBF jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRIBF
1D Price
Change %
BRIBF100%
N/A
HLVX - BRIBF
55%
Loosely correlated
N/A
NRSN - BRIBF
6%
Poorly correlated
-2.90%
VIGL - BRIBF
6%
Poorly correlated
N/A
IMMX - BRIBF
6%
Poorly correlated
-8.95%
GNTA - BRIBF
5%
Poorly correlated
+0.53%
More

GNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNTA has been loosely correlated with ROQAF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GNTA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
+0.53%
ROQAF - GNTA
37%
Loosely correlated
N/A
TNFA - GNTA
28%
Poorly correlated
-0.48%
BCYC - GNTA
26%
Poorly correlated
-3.82%
PHIO - GNTA
25%
Poorly correlated
-0.85%
SRRK - GNTA
24%
Poorly correlated
-6.40%
More